KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $230.0 million.

  • Gilead Sciences' Change in Account Payables fell 3593.31% to $230.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$95.0 million, marking a year-over-year decrease of 13114.75%. This contributed to the annual value of $290.0 million for FY2024, which is 18357.35% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Change in Account Payables is $230.0 million, which was down 3593.31% from -$162.0 million recorded in Q2 2025.
  • Gilead Sciences' 5-year Change in Account Payables high stood at $359.0 million for Q3 2024, and its period low was -$272.0 million during Q1 2023.
  • For the 5-year period, Gilead Sciences' Change in Account Payables averaged around $736842.1, with its median value being -$20.0 million (2021).
  • Examining YoY changes over the last 5 years, Gilead Sciences' Change in Account Payables showed a top increase of 133793.1% in 2024 and a maximum decrease of 266666.67% in 2024.
  • Over the past 5 years, Gilead Sciences' Change in Account Payables (Quarter) stood at $124.0 million in 2021, then skyrocketed by 112.9% to $264.0 million in 2022, then plummeted by 116.29% to -$43.0 million in 2023, then plummeted by 34.88% to -$58.0 million in 2024, then surged by 496.55% to $230.0 million in 2025.
  • Its Change in Account Payables stands at $230.0 million for Q3 2025, versus -$162.0 million for Q2 2025 and -$105.0 million for Q1 2025.